<style type="text/css"> .wpb_animate_when_almost_visible { opacity: 1; }</style>
  • Using technology in tumor genomics to develop precision cancer therapeutics

    Investor Relations

SEC Filings

Trovagene is publicly traded on the NASDAQ stock exchange under the symbol TROV.

NASDAQTROV
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventMar 15, 2017View HTMLDownload DOCDownload PDFDownload XLS
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Mar 15, 2017View HTMLDownload DOCDownload PDF
10-KAnnual report which provides a comprehensive overview of the company for the past yearMar 15, 2017View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventMar 7, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMar 2, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventFeb 28, 2017View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2017View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GJan 27, 2017View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJan 24, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJan 12, 2017View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJan 9, 2017View HTMLDownload DOCDownload PDFDownload XLS
4/AAmendment to a previously filed 4Jan 5, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Jan 5, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Jan 5, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Jan 5, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Jan 5, 2017View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Jan 5, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 4, 2017View HTMLDownload DOCDownload PDF
1-25      26-50      51-75

email print
3:34
3:34
Wistia video thumbnail - Susann-Berz Patient Video- Home Page

Thanks for reporting a problem. We'll attach technical data about this session to help us figure out the issue. Which of these best describes the problem?

Any other details or context?

Cancel
message